Physician

Ryan Mathew, M.D.

According to 2025 Medicare claims, Ryan Mathew, M.D. (NPI: 1043664899) practices rheumatology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is WV MEDICAL SERVICES PC (NPI: 1497739346; TIN: 631243197) and primary practice location at 35473-5163.

Mathew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 339 traditional Medicare patients, billed 31,519 HCPCS/CPT codes, and received $396,397 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,356 prescription claims across 423 beneficiaries totaling $2,030,551 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 20 claims. Open Payments data shows 171 records totaling $6,477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $348 to $2,030,551. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	27	40	$2,926
2022	212	6,298	$90,663
2023	413	33,348	$485,879
2024	339	31,519	$396,397

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	11	23	$348
2017	43	122	$11,365
2018	32	103	$10,722
2019	62	193	$14,123
2020	103	528	$141,381
2021	112	670	$143,766
2022	172	647	$166,710
2023	373	2,358	$1,192,820
2024	423	3,356	$2,030,551

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$694
2019	N/R	11	$483
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	20	$1,494
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	226	394	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	219	358	$12
80053	Blood test, comprehensive group of blood chemicals	247	474	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	206	414	$8
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	199	405	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	60	1,680	$520,939
Otezla	Apremilast	58	1,740	$286,150
Enbrel Sureclick	Etanercept	31	868	$238,873
Tremfya	Guselkumab	12	672	$161,752
Cosentyx Unoready Pen	Secukinumab	14	392	$101,915

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	170	$4,343	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$2,134	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan Mathew, M.D.?

Tedicare shows public-source Medicare data for Ryan Mathew, M.D. (NPI 1043664899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Mathew, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Mathew, M.D.?

Ryan Mathew, M.D. is linked to WV MEDICAL SERVICES PC (billing NPI 1497739346) in the available physician profile data.

Does Ryan Mathew, M.D. have Open Payments data?

Ryan Mathew, M.D. has 171 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.